Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Five Point Holdings, LLC stock logo
FPH
Five Point
$3.13
+4.7%
$3.08
$2.13
$3.74
$464.15M1.4192,681 shs238,985 shs
Laboratory Co. of America Holdings stock logo
LH
Laboratory Co. of America
$201.04
-0.1%
$209.84
$174.20
$234.09
$16.95B1.02764,281 shs802,517 shs
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
$12.80
+0.2%
$14.36
$12.53
$30.41
$2.17B0.974.84 million shs3.86 million shs
Teleflex Incorporated stock logo
TFX
Teleflex
$200.96
-1.0%
$216.73
$177.63
$262.97
$9.56B1.13283,820 shs468,990 shs
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$366.54
+0.4%
$377.90
$310.42
$415.73
$26.70B1.05515,319 shs332,532 shs
7 Stocks to Buy And Hold Forever Cover

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Five Point Holdings, LLC stock logo
FPH
Five Point
0.00%+3.46%-4.47%-9.12%+28.33%
Laboratory Co. of America Holdings stock logo
LH
Laboratory Co. of America
0.00%+1.47%-4.68%-8.30%-10.07%
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
0.00%-1.77%-11.86%-32.70%-51.13%
Teleflex Incorporated stock logo
TFX
Teleflex
0.00%-1.79%-6.35%-16.83%-21.30%
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
0.00%+1.27%-7.32%-8.20%-0.93%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Five Point Holdings, LLC stock logo
FPH
Five Point
0.7298 of 5 stars
0.03.00.00.01.80.81.9
Laboratory Co. of America Holdings stock logo
LH
Laboratory Co. of America
4.8955 of 5 stars
3.43.02.54.22.42.52.5
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
3.2442 of 5 stars
4.21.00.00.03.02.51.3
Teleflex Incorporated stock logo
TFX
Teleflex
4.9325 of 5 stars
3.35.01.73.92.52.52.5
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
4.8553 of 5 stars
2.45.01.73.23.32.53.1

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Five Point Holdings, LLC stock logo
FPH
Five Point
N/AN/AN/AN/A
Laboratory Co. of America Holdings stock logo
LH
Laboratory Co. of America
2.79
Moderate Buy$243.1420.94% Upside
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
2.35
Hold$18.7346.35% Upside
Teleflex Incorporated stock logo
TFX
Teleflex
2.67
Moderate Buy$261.7530.25% Upside
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
2.80
Moderate Buy$435.2018.73% Upside

Current Analyst Ratings

Latest TDOC, TFX, LH, FPH, and WST Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/3/2024
Teleflex Incorporated stock logo
TFX
Teleflex
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetHold ➝ Hold$240.00 ➝ $219.00
5/3/2024
Teleflex Incorporated stock logo
TFX
Teleflex
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold
4/29/2024
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$17.00 ➝ $15.00
4/26/2024
Laboratory Co. of America Holdings stock logo
LH
Laboratory Co. of America
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$270.00 ➝ $255.00
4/26/2024
Laboratory Co. of America Holdings stock logo
LH
Laboratory Co. of America
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$234.00 ➝ $213.00
4/26/2024
Laboratory Co. of America Holdings stock logo
LH
Laboratory Co. of America
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$255.00 ➝ $244.00
4/26/2024
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$26.00 ➝ $21.00
4/26/2024
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$25.00 ➝ $18.00
4/26/2024
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetIn-Line ➝ In-Line$15.00 ➝ $14.00
4/26/2024
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetHold ➝ Hold$16.00 ➝ $15.00
4/26/2024
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetHold ➝ Hold$21.00 ➝ $16.00
(Data available from 5/6/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Five Point Holdings, LLC stock logo
FPH
Five Point
$211.73M2.19$0.53 per share5.89$13.35 per share0.23
Laboratory Co. of America Holdings stock logo
LH
Laboratory Co. of America
$12.16B1.39$20.31 per share9.90$92.76 per share2.17
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
$2.60B0.83$0.81 per share15.75$14.05 per share0.91
Teleflex Incorporated stock logo
TFX
Teleflex
$3.00B3.15$18.64 per share10.78$94.49 per share2.13
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$2.93B9.12$10.22 per share35.86$39.31 per share9.32

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Five Point Holdings, LLC stock logo
FPH
Five Point
$55.39M$0.853.68N/A28.83%3.19%2.13%7/18/2024 (Estimated)
Laboratory Co. of America Holdings stock logo
LH
Laboratory Co. of America
$418M$4.9740.4512.601.513.52%14.68%7.03%7/25/2024 (Estimated)
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
-$220.37M-$1.41N/AN/AN/A-8.90%-10.13%-5.37%7/23/2024 (Estimated)
Teleflex Incorporated stock logo
TFX
Teleflex
$356.33M$6.2332.2613.231.959.82%14.78%8.79%8/1/2024 (Estimated)
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$593.40M$7.5848.3640.156.4319.42%20.57%15.47%7/25/2024 (Estimated)

Latest TDOC, TFX, LH, FPH, and WST Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/2/2024Q1 2024
Teleflex Incorporated stock logo
TFX
Teleflex
$3.07$3.21+$0.14$6.10$726.85 million$737.80 million      
4/25/2024Q1 2024
Laboratory Co. of America Holdings stock logo
LH
Laboratory Co. of America
$3.48$3.68+$0.20$4.67$3.12 billion$3.18 billion      
4/25/2024Q1 2024
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
-$0.47-$0.49-$0.02-$0.49$637.31 million$646.13 million    
4/25/2024Q1 2024
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$1.29$1.56+$0.27$1.57$670.62 million$695.40 million    
2/22/2024Q4 23
Teleflex Incorporated stock logo
TFX
Teleflex
$3.26$3.38+$0.12$6.10$769.01 million$773.90 million      
2/20/2024Q4 2023
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
-$0.22-$0.17+$0.05-$0.17$670.79 million$660.50 million      
2/15/2024Q4 2023
Laboratory Co. of America Holdings stock logo
LH
Laboratory Co. of America
$3.29$3.30+$0.01$8.55$3.02 billion$3.03 billion    
2/15/202412/31/2023
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$1.78$1.83+$0.05$1.83$740.43 million$732.00 million      

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Five Point Holdings, LLC stock logo
FPH
Five Point
N/AN/AN/AN/AN/A
Laboratory Co. of America Holdings stock logo
LH
Laboratory Co. of America
$2.881.43%N/A57.95%N/A
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
N/AN/AN/AN/AN/A
Teleflex Incorporated stock logo
TFX
Teleflex
$1.360.68%N/A21.83%N/A
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$0.800.22%+5.81%10.55%1 Years

Latest TDOC, TFX, LH, FPH, and WST Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/25/2024
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
Quarterly$0.200.22%7/31/20247/31/20248/7/2024
4/11/2024
Laboratory Co. of America Holdings stock logo
LH
Laboratory Co. of America
Quarterly$0.721.39%5/28/20245/28/20246/12/2024
2/20/2024
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
Quarterly$0.200.23%4/23/20244/24/20245/1/2024
2/22/2024
Teleflex Incorporated stock logo
TFX
Teleflex
Quarterly$0.340.57%2/29/20243/1/20243/15/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Five Point Holdings, LLC stock logo
FPH
Five Point
N/A
0.39
0.39
Laboratory Co. of America Holdings stock logo
LH
Laboratory Co. of America
0.39
0.88
0.76
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
0.67
3.82
3.74
Teleflex Incorporated stock logo
TFX
Teleflex
0.37
2.51
1.41
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
0.03
2.61
1.95

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Five Point Holdings, LLC stock logo
FPH
Five Point
38.09%
Laboratory Co. of America Holdings stock logo
LH
Laboratory Co. of America
95.94%
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
76.82%
Teleflex Incorporated stock logo
TFX
Teleflex
95.62%
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
93.90%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Five Point Holdings, LLC stock logo
FPH
Five Point
90148.29 million141.83 millionNot Optionable
Laboratory Co. of America Holdings stock logo
LH
Laboratory Co. of America
67,00084.30 million83.58 millionOptionable
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
5,600169.59 million167.98 millionOptionable
Teleflex Incorporated stock logo
TFX
Teleflex
14,50047.10 million46.43 millionOptionable
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
10,60072.84 million72.46 millionOptionable

TDOC, TFX, LH, FPH, and WST Headlines

SourceHeadline
West Pharmaceutical Services to Present at Bank of America Securities Healthcare ConferenceWest Pharmaceutical Services to Present at Bank of America Securities Healthcare Conference
msn.com - May 6 at 3:37 AM
Swiss National Bank Trims Position in West Pharmaceutical Services, Inc. (NYSE:WST)Swiss National Bank Trims Position in West Pharmaceutical Services, Inc. (NYSE:WST)
marketbeat.com - May 5 at 8:35 AM
TCG Advisory Services LLC Buys Shares of 2,225 West Pharmaceutical Services, Inc. (NYSE:WST)TCG Advisory Services LLC Buys Shares of 2,225 West Pharmaceutical Services, Inc. (NYSE:WST)
marketbeat.com - May 4 at 3:34 PM
Truist Financial Corp Cuts Holdings in West Pharmaceutical Services, Inc. (NYSE:WST)Truist Financial Corp Cuts Holdings in West Pharmaceutical Services, Inc. (NYSE:WST)
marketbeat.com - May 2 at 5:40 AM
West Pharmaceutical Services, Inc. (NYSE:WST) Receives Average Rating of "Moderate Buy" from BrokeragesWest Pharmaceutical Services, Inc. (NYSE:WST) Receives Average Rating of "Moderate Buy" from Brokerages
americanbankingnews.com - May 1 at 3:12 AM
West Pharmaceutical Services, Inc. (NYSE:WST) Q1 2024 Earnings Call TranscriptWest Pharmaceutical Services, Inc. (NYSE:WST) Q1 2024 Earnings Call Transcript
finance.yahoo.com - April 30 at 9:32 AM
West Pharmaceutical Services, Inc. (NYSE:WST) Shares Sold by Russell Investments Group Ltd.West Pharmaceutical Services, Inc. (NYSE:WST) Shares Sold by Russell Investments Group Ltd.
marketbeat.com - April 30 at 7:20 AM
West to Participate in Upcoming Investor ConferenceWest to Participate in Upcoming Investor Conference
prnewswire.com - April 30 at 6:00 AM
West Pharmaceutical Services Posts Q1 2024 Financial Results, Updates Full-Year GuidanceWest Pharmaceutical Services Posts Q1 2024 Financial Results, Updates Full-Year Guidance
msn.com - April 29 at 8:30 AM
William Blair Research Analysts Lift Earnings Estimates for West Pharmaceutical Services, Inc. (NYSE:WST)William Blair Research Analysts Lift Earnings Estimates for West Pharmaceutical Services, Inc. (NYSE:WST)
americanbankingnews.com - April 29 at 2:28 AM
Paradiem LLC Has $3.49 Million Stake in West Pharmaceutical Services, Inc. (NYSE:WST)Paradiem LLC Has $3.49 Million Stake in West Pharmaceutical Services, Inc. (NYSE:WST)
marketbeat.com - April 28 at 1:50 PM
West Pharmaceutical Services, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their PredictionsWest Pharmaceutical Services, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
finance.yahoo.com - April 28 at 12:07 PM
West Pharmaceutical Services, Inc. (WST) Q1 2024 Earnings Call TranscriptWest Pharmaceutical Services, Inc. (WST) Q1 2024 Earnings Call Transcript
seekingalpha.com - April 27 at 4:03 PM
Bank Julius Baer & Co. Ltd Zurich Purchases Shares of 8,207 West Pharmaceutical Services, Inc. (NYSE:WST)Bank Julius Baer & Co. Ltd Zurich Purchases Shares of 8,207 West Pharmaceutical Services, Inc. (NYSE:WST)
marketbeat.com - April 27 at 8:31 AM
Stevens Capital Management LP Purchases New Stake in West Pharmaceutical Services, Inc. (NYSE:WST)Stevens Capital Management LP Purchases New Stake in West Pharmaceutical Services, Inc. (NYSE:WST)
marketbeat.com - April 26 at 5:57 PM
West Pharmaceutical Services: Strong Q1 Performance and Upbeat FY24 Outlook Bolster Buy RatingWest Pharmaceutical Services: Strong Q1 Performance and Upbeat FY24 Outlook Bolster Buy Rating
markets.businessinsider.com - April 26 at 2:59 PM
West Pharmaceutical Services (NYSE:WST) Releases Quarterly  Earnings Results, Beats Expectations By $0.27 EPSWest Pharmaceutical Services (NYSE:WST) Releases Quarterly Earnings Results, Beats Expectations By $0.27 EPS
marketbeat.com - April 26 at 11:48 AM
West Pharmaceutical Services First Quarter 2024 Earnings: Beats ExpectationsWest Pharmaceutical Services First Quarter 2024 Earnings: Beats Expectations
finance.yahoo.com - April 26 at 9:58 AM
West Pharmaceutical Services, Inc. Declares Quarterly Dividend of $0.20 (NYSE:WST)West Pharmaceutical Services, Inc. Declares Quarterly Dividend of $0.20 (NYSE:WST)
marketbeat.com - April 26 at 8:00 AM
West Pharmaceutical Services Inc (WST) Q1 2024 Earnings Call Transcript Highlights: Navigating ...West Pharmaceutical Services Inc (WST) Q1 2024 Earnings Call Transcript Highlights: Navigating ...
finance.yahoo.com - April 26 at 4:58 AM
Beyond The Earnings: What The Latest SEC 10-Q Filing Reveals About West Pharmaceutical Services, Inc. (WST) FutureBeyond The Earnings: What The Latest SEC 10-Q Filing Reveals About West Pharmaceutical Services, Inc. (WST) Future
americanbankingnews.com - April 26 at 4:06 AM
West Pharmaceutical Services, Inc. 2024 Q1 - Results - Earnings Call PresentationWest Pharmaceutical Services, Inc. 2024 Q1 - Results - Earnings Call Presentation
seekingalpha.com - April 25 at 5:43 PM
West Pharmaceutical (WST) Q1 Earnings Beat, HVP Sales WeakWest Pharmaceutical (WST) Q1 Earnings Beat, HVP Sales Weak
zacks.com - April 25 at 11:35 AM
West Pharmaceutical Services, Inc.: West Announces First-Quarter 2024 Results and Declares Third-Quarter 2024 DividendWest Pharmaceutical Services, Inc.: West Announces First-Quarter 2024 Results and Declares Third-Quarter 2024 Dividend
finanznachrichten.de - April 25 at 8:55 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Five Point logo

Five Point

NYSE:FPH
Five Point Holdings, LLC, through its subsidiary, Five Point Operating Company, LP, owns and develops mixed-use and planned communities in Orange County, Los Angeles County, and San Francisco County. The company operates in four segments: Valencia, San Francisco, Great Park, and Commercial. It sells residential and commercial land sites to homebuilders, commercial developers, and commercial buyers; operates and owns a commercial office, research and development, medical campus, and other properties; and provides development and property management services. The company was formerly known as Newhall Holding Company, LLC and changed its name to Five Point Holdings, LLC in May 2016. Five Point Holdings, LLC was incorporated in 2009 and is headquartered in Irvine, California.
Laboratory Co. of America logo

Laboratory Co. of America

NYSE:LH
Laboratory Corporation of America Holdings operates as a life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Biopharma Laboratory Services (BLS). The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C and vitamin D, prostate-specific antigens, tests for sexually transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases; services related to anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, parentage and donor testing, occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests; and health and wellness services to employers and managed care organizations (MCOs), including health fairs, on-site and at-home testing, vaccinations, and health screenings. In addition, the company offers online and mobile applications that enable patients to check test results; online applications for providers, MCOs, and accountable care organizations; and drug development, medical device, and companion diagnostic development solutions from early-stage research to clinical development, as well as support for crop protection and chemical testing. It serves pharmaceutical, biotechnology, medical device, and diagnostics companies; and MCOs, employer plans, other health insurance providers, governmental agencies, physicians and other healthcare providers, hospitals and health systems, employers, patients and consumers, contract research organizations, crop protection and chemical companies, academic institutions, independent clinical laboratories, and retailers. The company was incorporated in 1994 and is headquartered in Burlington, North Carolina.
Teladoc Health logo

Teladoc Health

NYSE:TDOC
Teladoc Health, Inc. provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems. The BetterHelp segment operates a mental health platform that provides online counseling and therapy services through website, mobile applications, phones, and text-based interactions by its licensed clinicians. The company offers its products and services under the Teladoc, Livongo, and BetterHelp brands. It serves employers, health plans, hospitals and health systems, and insurance and financial services companies, as well as individual members. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. Teladoc Health, Inc. was incorporated in 2002 and is headquartered in Purchase, New York.
Teleflex logo

Teleflex

NYSE:TFX
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. It also offers interventional products, which consists of various coronary catheters, structural heart support devices, and peripheral intervention and mechanical circulatory support platform that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded pumps and catheters, Guideline, Turnpike, and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. The company provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. It also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings; urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. Teleflex Incorporated was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.
West Pharmaceutical Services logo

West Pharmaceutical Services

NYSE:WST
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. This segment also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. The company serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.